References

Membrane fusion by an RGD-containing sequence from the core protein VP3 of hepatitis A virus and the RGA-analogue: implications for viral infection

10.1002/1097-0282(200101)58:1<63::aid-bip70>3.0.co;2-l · ExternalCitation · doi-reference

Molecular epidemiology of the hepatitis C virus in Western Siberia

10.1002/jmv.20467 · ExternalCitation · doi-reference

Distribution and diversity of hepatitis B virus genotypes in Yunnan, China

10.1002/jmv.24002 · ExternalCitation · doi-reference

Molecular epidemiology of hepatitis A virus infection in Northeast India

10.1002/jmv.24168 · ExternalCitation · doi-reference

Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe

10.1002/jmv.24641 · ExternalCitation · doi-reference

Comparative genomics of hepatitis A virus, hepatitis C virus, and hepatitis E virus provides insights into the evolutionary history of Hepatovirus species

10.1002/mbo3.973 · ExternalCitation · doi-reference

The pathogenesis of human cytomegalovirus

10.1002/path.4437 · ExternalCitation · doi-reference

Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time

10.1007/s00705-012-1369-9 · ExternalCitation · doi-reference

Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: Oncoprotein targets and clinical implications

10.1007/s12032-025-02610-x · ExternalCitation · doi-reference

The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication

10.1007/s12250-016-3924-0 · ExternalCitation · doi-reference

The foodborne transmission of hepatitis E virus to humans

10.1007/s12560-021-09461-5 · ExternalCitation · doi-reference

Herpes simplex virus: Epidemiology, diagnosis, and treatment

10.1016/0002-9378(69)90623-1 · ExternalCitation · doi-reference

The hepatitis B virus and the host response

10.1016/0168-8278(90)90170-v · ExternalCitation · doi-reference

Yellow fever virus: Genetic and phenotypic diversity and implications for detection, prevention and therapy

10.1016/j.antiviral.2014.12.010 · ExternalCitation · doi-reference

Hepatitis B virus biology and life cycle

10.1016/j.antiviral.2020.104925 · ExternalCitation · doi-reference

Hepatitis D virus: improving virological knowledge to develop new treatments

10.1016/j.antiviral.2022.105461 · ExternalCitation · doi-reference

Management of viral hepatitis A, C, D and E in pregnancy

10.1016/j.bpobgyn.2020.03.009 · ExternalCitation · doi-reference

Hepatitis B virus-induced hepatocellular carcinoma

10.1016/j.canlet.2013.08.035 · ExternalCitation · doi-reference

Hepatitis C virus-associated non-Hodgkin lymphomas: biology, epidemiology, and treatment

10.1016/j.cld.2017.03.006 · ExternalCitation · doi-reference

Virological and immunological determinants of hepatitis E virus infection outcomes

10.1016/j.coviro.2025.101491 · ExternalCitation · doi-reference

Chronic Epstein-Barr virus infection: A potential junction between primary Sjögren's syndrome and lymphoma

10.1016/j.cyto.2023.156227 · ExternalCitation · doi-reference

Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: a cohort study

10.1016/j.ejogrb.2022.07.009 · ExternalCitation · doi-reference

Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces

10.1016/j.fm.2012.04.007 · ExternalCitation · doi-reference

Hepatitis E virus and the liver: clinical settings and liver pathology

10.1016/j.gtc.2017.01.010 · ExternalCitation · doi-reference

Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce

10.1016/j.ijfoodmicro.2011.08.011 · ExternalCitation · doi-reference

Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity

10.1016/j.jaut.2018.10.021 · ExternalCitation · doi-reference

Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges

10.1016/j.jhep.2010.12.031 · ExternalCitation · doi-reference

The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis

10.1016/j.jhep.2020.04.008 · ExternalCitation · doi-reference

Stability of hepatitis C virus RNA and anti-HCV antibody in air-dried and freeze-dried human plasma samples

10.1016/j.jviromet.2017.12.004 · ExternalCitation · doi-reference

Hepatitis A virus: host interactions, molecular epidemiology and evolution

10.1016/j.meegid.2013.10.023 · ExternalCitation · doi-reference

Human cytomegalovirus-encoded microRNAs: A master regulator of latent infection

10.1016/j.meegid.2019.104119 · ExternalCitation · doi-reference

Changing molecular epidemiology of hepatitis A virus in Santiago, Chile from 2010 to 2021

10.1016/j.meegid.2023.105428 · ExternalCitation · doi-reference

Molecular epidemiology of hepatitis B virus (HBV) in Ethiopia: a review article

10.1016/j.meegid.2024.105618 · ExternalCitation · doi-reference

Pathogenicity of duck hepatitis A virus type 3 and innate immune responses of the ducklings to virulent DHAV-3

10.1016/j.molimm.2018.01.007 · ExternalCitation · doi-reference

Hepatitis B virus: from diagnosis to treatment

10.1016/j.patbio.2010.05.002 · ExternalCitation · doi-reference

Single-cell RNA sequencing reveals intrahepatic signature related to pathobiology of duck hepatitis A virus type 3 (DHAV-3) infection

10.1016/j.psj.2025.104798 · ExternalCitation · doi-reference

Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: a systematic review

10.1016/j.puhe.2026.106384 · ExternalCitation · doi-reference

Disparities in hepatitis A virus (HAV) vaccination coverage among adult travelers to intermediate or high-risk countries: The role of birthplace and race/ethnicity

10.1016/j.vaccine.2019.05.071 · ExternalCitation · doi-reference

Molecular biology of hepatitis B virus infection

10.1016/j.virol.2015.02.031 · ExternalCitation · doi-reference

The infectivity and pathogenicity of hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice

10.1016/j.virs.2022.07.009 · ExternalCitation · doi-reference

Genetic variability and molecular evolution of hepatitis A virus

10.1016/j.virusres.2007.01.005 · ExternalCitation · doi-reference

Full-length sequences of subgenotype IIIA and IIIB hepatitis A virus isolates: characterization of genotype III HAV genomes

10.1016/j.virusres.2007.02.005 · ExternalCitation · doi-reference

Mechanisms of inactivation of hepatitis A virus in water by chlorine dioxide

10.1016/j.watres.2003.12.021 · ExternalCitation · doi-reference

Viral hepatitis: recent developments and prospects for prevention

10.1016/s0022-3476(75)80118-1 · ExternalCitation · doi-reference

Epidemiology and ecology of yellow fever virus

10.1016/s0065-3527(03)61007-9 · ExternalCitation · doi-reference

Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors

10.1016/s1726-4901(09)70346-6 · ExternalCitation · doi-reference

Accelerating the elimination of viral hepatitis: A Lancet Gastroenterology & Hepatology Commission

10.1016/s2468-1253(18)30270-x · ExternalCitation · doi-reference

Hepatitis B and C in pregnancy: A review and recommendations for care

10.1038/jp.2014.167 · ExternalCitation · doi-reference

Exosome mimicry by a HAVCR1-NPC1 pathway of endosomal fusion mediates hepatitis A virus infection

10.1038/s41564-020-0740-y · ExternalCitation · doi-reference

Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load

10.1038/s41598-017-04479-x · ExternalCitation · doi-reference

Hepatitis C virus biology

10.1038/sj.cdd.4401121 · ExternalCitation · doi-reference

Detection of hepatitis A viral RNA in sera of patients with acute hepatitis A

10.1046/j.1440-1746.2000.02291.x · ExternalCitation · doi-reference

Hepatitis B viral genotypes: clinical relevance and molecular characteristics

10.1046/j.1440-1746.2002.02737.x · ExternalCitation · doi-reference

Current concepts of viral hepatitis and a peek into the future

10.1053/gast.1999.0029900506a · ExternalCitation · doi-reference

Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection

10.1053/j.gastro.2007.12.011 · ExternalCitation · doi-reference

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses

10.1073/pnas.1107087108 · ExternalCitation · doi-reference

Molecular cloning and characterization of hepatitis A virus cDNA

10.1073/pnas.80.19.5885 · ExternalCitation · doi-reference

Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany

10.1080/03007995.2018.1482264 · ExternalCitation · doi-reference

Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials

10.1080/13543784.2021.1977795 · ExternalCitation · doi-reference

Oncolytic herpes simplex virus therapy for Malignant glioma: Current approaches to successful clinical application

10.1080/14712598.2019.1614557 · ExternalCitation · doi-reference

Human cytomegalovirus (HCMV)-encoded microRNAs: Potential biomarkers and clinical applications

10.1080/15476286.2021.1930757 · ExternalCitation · doi-reference

Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma

10.1080/21505594.2024.2421231 · ExternalCitation · doi-reference

Viral hepatitis vaccination during pregnancy

10.1080/21645515.2015.1132129 · ExternalCitation · doi-reference

Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review

10.1080/21645515.2016.1242539 · ExternalCitation · doi-reference

Hepatitis A outbreaks in developed countries: detection, control, and prevention

10.1089/fpd.2019.2648 · ExternalCitation · doi-reference

Molecular characterization of hamster-adapted yellow fever virus

10.1089/vbz.2019.2495 · ExternalCitation · doi-reference

Human cytomegalovirus infection and cardiovascular disease: Current perspectives

10.1089/vim.2022.0139 · ExternalCitation · doi-reference

Psychosocial factors and the care cascade for hepatitis C treatment colocated at a syringe service program

10.1093/infdis/jiaa142 · ExternalCitation · doi-reference

Herpes simplex virus neurovirulence across the human lifespan

10.1093/infdis/jiaf275 · ExternalCitation · doi-reference

Viral hepatitis B: Clinical and epidemiological characteristics

10.1101/cshperspect.a024935 · ExternalCitation · doi-reference

History of the discovery of hepatitis A virus

10.1101/cshperspect.a031740 · ExternalCitation · doi-reference

IL-35: a potential therapeutic target for controlling hepatitis B virus infection

10.1111/1751-2980.12218 · ExternalCitation · doi-reference

Epidemiology of hepatitis B virus in non-institutionalized children and adolescents affected by handicap

10.1111/j.1365-2788.1993.tb01286.x · ExternalCitation · doi-reference

Chronic hepatitis B: Early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides

10.1111/j.1365-2893.2009.01078.x · ExternalCitation · doi-reference

Epidemiology of the hepatitis C virus

10.1111/j.1423-0410.1998.tb05412.x · ExternalCitation · doi-reference

Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression

10.1111/j.1478-3231.2010.02423.x · ExternalCitation · doi-reference

Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinoma

10.1111/j.1523-1755.2004.00601.x · ExternalCitation · doi-reference

Hepatitis B virus in the Maghreb region: from epidemiology to prospective research

10.1111/liv.12135 · ExternalCitation · doi-reference

Immunology of hepatitis D virus infection: general concepts and present evidence

10.1111/liv.15424 · ExternalCitation · doi-reference

Update on diagnosis, management, and prevention of hepatitis B virus infection

10.1128/cmr.12.2.351 · ExternalCitation · doi-reference

Yellow fever virus: Diagnostics for a persistent arboviral threat

10.1128/jcm.00827-18 · ExternalCitation · doi-reference

High-performance enrichment-based genome sequencing to support the investigation of hepatitis A virus outbreaks

10.1128/spectrum.02834-23 · ExternalCitation · doi-reference

Study protocol: Epidemiological and clinical characteristics of acute viral hepatitis in Brazilian health services

10.1136/bmjopen-2020-045852 · ExternalCitation · doi-reference

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease

10.1136/gutjnl-2020-323888 · ExternalCitation · doi-reference

Hepatitis E virus: animal models and zoonosis

10.1146/annurev-animal-020518-115117 · ExternalCitation · doi-reference

Hepatitis A: viral structure, classification, life cycle, clinical symptoms, diagnosis error, and vaccination

10.1155/2023/4263309 · ExternalCitation · doi-reference

Molecular mechanisms and therapeutic targets of hepatitis B virus pre-S mutant-associated hepatocellular carcinoma tumorigenesis

10.1177/10732748251320492 · ExternalCitation · doi-reference

Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A

10.1186/1743-422x-8-254 · ExternalCitation · doi-reference

Hepatitis A virus subgenotyping based on RT-qPCR assays

10.1186/s12866-014-0296-1 · ExternalCitation · doi-reference

Molecular characteristics of hepatitis B virus among students and pregnant women in Chad

10.1186/s12879-025-11226-5 · ExternalCitation · doi-reference

Human cytomegalovirus: pathogenesis, prevention, and treatment

10.1186/s43556-024-00226-7 · ExternalCitation · doi-reference

Questionnaire survey on knowledge, attitudes, and behaviour towards viral hepatitis among the Hong Kong public

10.12809/hkmj219463 · ExternalCitation · doi-reference

Characterization of the virus-host RNA-RNA interactome across important human pathogenic RNA viruses

10.1371/journal.ppat.1014217 · ExternalCitation · doi-reference

Molecular characteristics of the full-length genome of occult hepatitis B virus from blood donors in China

10.21203/rs.3.rs-1267803/v1 · ExternalCitation · doi-reference

Hepatitis C virus, oxidative stress and steatosis: current status and perspectives

10.2174/156652411795976592 · ExternalCitation · doi-reference

Transfusion-transmitted occult hepatitis B virus infection: current understanding, challenges, and its implication in blood safety

10.3389/fimmu.2025.1663306 · ExternalCitation · doi-reference

Virus-driven remodeling of the immune microenvironment and response to immune checkpoint inhibitors: the infection- immunity-cancer crosstalk

10.3389/fimmu.2026.1807408 · ExternalCitation · doi-reference

Molecular and biological characterization of hepatitis B virus subgenotype F1b clusters: unraveling its role in hepatocarcinogenesis

10.3389/fmicb.2022.946703 · ExternalCitation · doi-reference

Transcriptional analysis of duck liver infected with duck hepatitis A virus type 1 isolate HA5

10.3389/fvets.2026.1739363 · ExternalCitation · doi-reference

The role of epigenetic mechanisms in the pathogenesis of hepatitis C infection

10.3390/biom14080986 · ExternalCitation · doi-reference

Hepatitis C virus infection: host-virus interaction and mechanisms of viral persistence

10.3390/cells8040376 · ExternalCitation · doi-reference

Mechanisms of DNA methylation in virus-host interaction in hepatitis B infection: pathogenesis and oncogenetic properties

10.3390/ijms22189858 · ExternalCitation · doi-reference

Biomarkers in detection of hepatitis C virus infection

10.3390/pathogens13040331 · ExternalCitation · doi-reference

Viral hepatitis: Host immune interaction, pathogenesis and new therapeutic strategies

10.3390/pathogens13090766 · ExternalCitation · doi-reference

Hepatitis E virus assembly and release

10.3390/v11060539 · ExternalCitation · doi-reference

Yellow fever: Integrating current knowledge with technological innovations to identify strategies for controlling a re-emerging virus

10.3390/v11100960 · ExternalCitation · doi-reference

Epstein-Barr virus and peri-implantitis: A systematic review and meta-analysis

10.3390/v13020250 · ExternalCitation · doi-reference

Toward the eradication of herpes simplex virus: Vaccination and beyond

10.3390/v16091476 · ExternalCitation · doi-reference

Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease

10.3390/v5051292 · ExternalCitation · doi-reference

Advanced molecular surveillance of hepatitis C virus

10.3390/v7031153 · ExternalCitation · doi-reference

Host-targeting agents to prevent and cure hepatitis C virus infection

10.3390/v7112898 · ExternalCitation · doi-reference

Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection

10.3748/wjg.14.7149 · ExternalCitation · doi-reference

Hepatitis C virus proteins

10.3748/wjg.v13.i17.2406 · ExternalCitation · doi-reference

Hepatitis C virus: virology, diagnosis and management of antiviral therapy

10.3748/wjg.v13.i17.2461 · ExternalCitation · doi-reference

Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina

10.3748/wjg.v19.i35.5813 · ExternalCitation · doi-reference

Scotomas in molecular virology and epidemiology of hepatitis C virus

10.3748/wjg.v19.i44.7910 · ExternalCitation · doi-reference

Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis

10.3748/wjg.v19.i9.1342 · ExternalCitation · doi-reference

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

10.3748/wjg.v20.i13.3410 · ExternalCitation · doi-reference

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen

10.3748/wjg.v20.i23.7089 · ExternalCitation · doi-reference

Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war

10.3748/wjg.v21.i13.3786 · ExternalCitation · doi-reference

Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's

10.3748/wjg.v21.i35.10150 · ExternalCitation · doi-reference

Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations

10.3748/wjg.v24.i38.4330 · ExternalCitation · doi-reference

Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma

10.3748/wjg.v25.i1.42 · ExternalCitation · doi-reference

Development of Epstein-Barr virus-associated gastric cancer: Infection, inflammation, and oncogenesis

10.3748/wjg.v28.i44.6249 · ExternalCitation · doi-reference

Prevention and management of hepatitis B virus reactivation in patients with hematological Malignancies in the targeted therapy era

10.3748/wjg.v29.i33.4942 · ExternalCitation · doi-reference

Mechanism of hepatitis C virus-mediated development and progression of liver cirrhosis and hepatocellular carcinoma

10.3748/wjg.v32.i7.115234 · ExternalCitation · doi-reference

Treatment options for nonresponders and relapsers to initial therapy for hepatitis C

10.3949/ccjm.70.suppl_4.s21 · ExternalCitation · doi-reference

Current epidemiological trends and public health challenges of hepatitis A virus infection in Thailand

10.4269/ajtmh.25-0083 · ExternalCitation · doi-reference

Prevention, diagnosis, evaluation, and treatment of hepatitis C virus infection in chronic kidney disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline

10.7326/m19-1539 · ExternalCitation · doi-reference